$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What are the effects and side effects of erlotinib?
2025-10-19 11:44:20
Check Details
Will Erlotinib be launched in 2024?
2025-10-19 11:44:20
Check Details
When will sotoraxibu be available in China? _ Kanghule
2025-10-19 11:44:20
Check Details
Efficacy and effects of Mobocertinib
2025-10-19 11:44:20
Check Details
What are the precautions and contraindications of the new lung cancer drug Platinib?
2025-10-19 11:44:20
Check Details
Where can I buy the new lung cancer drug Platinib? _ Kanghule
2025-10-19 11:44:20
Check Details
Can genuine Mobotinib be purchased in the country? _ Kanghule
2025-10-19 11:44:20
Check Details
Where can I buy genuine larotrectinib in China?
2025-10-19 11:44:20
Check Details
How long will it take for the side effects of Capmatinib to appear? _ Kanghule
2025-10-19 11:44:20
Check Details
What are the applications and fields of capmatinib?
2025-10-19 11:44:20
Check Details
What are the purchase and medical insurance of Serpatinib?
2025-10-19 11:44:20
Check Details
What is the effect of dacomitinib on entering the brain and controlling bone metastasis?
2025-10-19 11:44:20
Check Details
1
2
...
4134
4135
4136
4137
4138
4139
4140
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
2
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
3
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
4
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
5
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
6
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
7
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
8
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
9
Vemurafenib (Zelboraf) Complete Medication Guide
10
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
11
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
12
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options